CIK 0001357874
- Non-accelerated filer
- Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 20,000 shares at $9.38 ($187,600)
- 4 Open-market sale Chief Scientific Officer sold 9,673 shares at $9.17 ($88,701)
- 4 Open-market sale President and CEO sold 9,675 shares at $8.96 ($86,688)
- 4 Open-market sale Chief Scientific Officer sold 19,349 shares at an average $8.93 ($172,883)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale President and CEO sold 19,488 shares at an average $8.41 ($163,893)
- 3 Insider Initial Statement of Ownership
- 4 Exercise or conversion President and CEO acquired 13,422 shares (option exercise)
- 4 Open-market sale Chief Scientific Officer sold 9,676 shares at $8.69 ($84,084)
Page 10 of 14 · 269 filings